Devyser Diagnostics AB (publ)
DVYSR.ST
Price:
$112.2
Market Cap:
$1.86B
Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-12-10
Stock Exchange
STO
Ticker
DVYSR.ST
PE Ratio
[-73.82]
ROE
[-7.42%]
Current Ratio
[2.78]
Dividend Yield
[0%]
Enterprise Value
[1.82B]
Dividend History
The ROE as of December 2025 (TTM) for Devyser Diagnostics AB (publ) (DVYSR.ST) is -7.42%
According to Devyser Diagnostics AB (publ)’s latest financial reports and current stock price. The company's current ROE is -7.42%. This represents a change of 292.78% compared to the average of -1.89% of the last 4 quarters.
Devyser Diagnostics AB (publ) (DVYSR.ST) Historical ROE (quarterly & annually)
How has DVYSR.ST ROE performed in the past?
The mean historical ROE of Devyser Diagnostics AB (publ) over the last ten years is -8.85%. The current -7.42% ROE has changed -16.16% with respect to the historical average. Over the past ten years (40 quarters), DVYSR.ST's ROE was at its highest in in the June 2025 quarter at 0.38%. The ROE was at its lowest in in the September 2024 quarter at -6.65%.
Average
-8.85%
Median
-10.65%
Minimum
-35.46%
Maximum
18.94%
Devyser Diagnostics AB (publ) (DVYSR.ST) ROE by Quarter and Year
Discovering the peaks and valleys of Devyser Diagnostics AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 993.52%
Maximum Annual ROE = 18.94%
Minimum Annual Increase = -287.22%
Minimum Annual ROE = -35.46%
| Year | ROE | Change |
|---|---|---|
| 2024 | -17.62% | 26.57% |
| 2023 | -13.92% | 30.68% |
| 2022 | -10.65% | 114.12% |
| 2021 | -4.97% | -85.97% |
| 2020 | -35.46% | -287.22% |
| 2019 | 18.94% | 993.52% |
Devyser Diagnostics AB (publ) (DVYSR.ST) Average ROE
How has DVYSR.ST ROE performed in the past?
The current ROE of Devyser Diagnostics AB (publ) (DVYSR.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-14.06%
5-year avg
-16.52%
10-year avg
-8.85%
Devyser Diagnostics AB (publ) (DVYSR.ST) ROE vs. Peers
How is DVYSR.ST’s ROE compared to its peers?
Devyser Diagnostics AB (publ)’s ROE is greater than Carasent AB (publ) (-3.86%), less than Saniona AB (publ) (150.88%), greater than BioInvent International AB (publ) (-41.14%), greater than Egetis Therapeutics AB (publ) (-85.57%), less than Humana AB (publ) (7.55%), greater than OssDsign AB (publ) (-15.07%), less than Stille AB (5.85%), greater than BICO Group AB (publ) (-7.46%), less than Paxman AB (publ) (1.49%), greater than Vicore Pharma Holding AB (publ) (-44.02%),
| Company | ROE | Market cap |
|---|---|---|
| -3.86% | $1.85B | |
| 150.88% | $3.02B | |
| -41.14% | $1.93B | |
| -85.57% | $1.84B | |
| 7.55% | $2.45B | |
| -15.07% | $1.27B | |
| 5.85% | $1.77B | |
| -7.46% | $1.30B | |
| 1.49% | $1.23B | |
| -44.02% | $2.32B |
Build a custom stock screener for Devyser Diagnostics AB (publ) (DVYSR.ST) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Devyser Diagnostics AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Devyser Diagnostics AB (publ) (DVYSR.ST) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Devyser Diagnostics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Devyser Diagnostics AB (publ)'s ROE?
How is the ROE calculated for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the highest ROE for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the 3-year average ROE for Devyser Diagnostics AB (publ) (DVYSR.ST)?
What is the 5-year average ROE for Devyser Diagnostics AB (publ) (DVYSR.ST)?
How does the current ROE for Devyser Diagnostics AB (publ) (DVYSR.ST) compare to its historical average?